These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23821193)

  • 1. The role of LOX and LOXL2 in scar formation after glaucoma surgery.
    Van Bergen T; Marshall D; Van de Veire S; Vandewalle E; Moons L; Herman J; Smith V; Stalmans I
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5788-96. PubMed ID: 23821193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery.
    Li Z; Van Bergen T; Van de Veire S; Van de Vel I; Moreau H; Dewerchin M; Maudgal PC; Zeyen T; Spileers W; Moons L; Stalmans I
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5217-25. PubMed ID: 19474408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of LOX and LOXL2 in the Pathogenesis of an Experimental Model of Choroidal Neovascularization.
    Van Bergen T; Spangler R; Marshall D; Hollanders K; Van de Veire S; Vandewalle E; Moons L; Herman J; Smith V; Stalmans I
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5280-9. PubMed ID: 26258612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Losartan Attenuates Scar Formation in Filtering Bleb After Trabeculectomy.
    Shi H; Wang H; Fu S; Xu K; Zhang X; Xiao Y; Ye W
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1478-1486. PubMed ID: 28273314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit.
    Memarzadeh F; Varma R; Lin LT; Parikh JG; Dustin L; Alcaraz A; Eliott D
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3233-7. PubMed ID: 19182254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of different VEGF isoforms in scar formation after glaucoma filtration surgery.
    Van Bergen T; Vandewalle E; Van de Veire S; Dewerchin M; Stassen JM; Moons L; Stalmans I
    Exp Eye Res; 2011 Nov; 93(5):689-99. PubMed ID: 21907194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forkhead domain inhibitory-6 attenuates subconjunctival fibrosis in rabbit model with trabeculectomy.
    Lan C; Tan J; Tang L; Liu G; Huang L; Luo X; Zhou L; Zhu Y; Liu X; Fan N
    Exp Eye Res; 2021 Sep; 210():108725. PubMed ID: 34375589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of bevacizumab on wound healing modulation in an experimental trabeculectomy model.
    Ozgonul C; Mumcuoglu T; Gunal A
    Curr Eye Res; 2014 May; 39(5):451-9. PubMed ID: 24215335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysyl oxidase-like 2 level and glaucoma surgical outcomes.
    Park HY; Kim JH; Park CK
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3337-43. PubMed ID: 24764069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosmarinic Acid Suppresses Subconjunctival Neovascularization in Experimental Glaucoma Surgery.
    Ferreira Jde L; Chahud F; Ramalho LN; Modulo CM; Vieira LC; Reinach PS; Rodrigues Mde L; Cunha AS; Paula JS
    Curr Eye Res; 2015; 40(11):1134-40. PubMed ID: 25494917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II as a morphogenic cytokine stimulating fibrogenesis of human tenon's capsule fibroblasts.
    Shi H; Zhang Y; Fu S; Lu Z; Ye W; Xiao Y
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):855-64. PubMed ID: 25564450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of placental growth factor improves surgical outcome of glaucoma surgery.
    Van Bergen T; Jonckx B; Hollanders K; Sijnave D; Van de Velde S; Vandewalle E; Moons L; Stassen JM; Stalmans I
    J Cell Mol Med; 2013 Dec; 17(12):1632-43. PubMed ID: 24118824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of trastuzumab on wound healing in experimental glaucoma surgery.
    Turgut B; Eren K; Akin MM; Bilir Can N; Demir T
    Clin Exp Ophthalmol; 2015; 43(1):67-76. PubMed ID: 24801440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours.
    Zaffryar-Eilot S; Marshall D; Voloshin T; Bar-Zion A; Spangler R; Kessler O; Ghermazien H; Brekhman V; Suss-Toby E; Adam D; Shaked Y; Smith V; Neufeld G
    Carcinogenesis; 2013 Oct; 34(10):2370-9. PubMed ID: 23828904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lowered Decorin With Aberrant Extracellular Matrix Remodeling in Aqueous Humor and Tenon's Tissue From Primary Glaucoma Patients.
    NikhalaShree S; Karthikkeyan G; George R; Shantha B; Vijaya L; Ratra V; Sulochana KN; Coral K
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4661-4669. PubMed ID: 31725165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator modifies healing of glaucoma filtering surgery in rabbits.
    Fourman S; Wiley L
    Ophthalmic Surg; 1991 Dec; 22(12):718-23. PubMed ID: 1787936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with bevacizumab and 5-fluorouracil attenuates the postoperative scarring response after experimental glaucoma filtration surgery.
    How A; Chua JL; Charlton A; Su R; Lim M; Kumar RS; Crowston JG; Wong TT
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):928-32. PubMed ID: 19797222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A p38 MAPK inhibitor improves outcome after glaucoma filtration surgery.
    Nassar K; Tura A; Lüke J; Lüke M; Grisanti S; Grisanti S
    J Glaucoma; 2015 Feb; 24(2):165-78. PubMed ID: 25493622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery.
    Zhang F; Liu K; Cao M; Qu J; Zhou D; Pan Z; Duan X; Zhou Y
    Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2743-2752. PubMed ID: 31247081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery.
    Zhong H; Sun G; Lin X; Wu K; Yu M
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3136-42. PubMed ID: 21330661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.